BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20964489)

  • 21. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients.
    Machado LY; Dubed M; Díaz H; Ruiz N; Romay D; Váldes N; Blanco M; Silva E
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):411-4. PubMed ID: 22985307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil.
    Rodrigues R; Scherer LC; Oliveira CM; Franco HM; Sperhacke RD; Ferreira JL; Castro SM; Stella IM; Brigido LF
    Virus Res; 2006 Mar; 116(1-2):201-7. PubMed ID: 16332398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L; Stuyver L; Van Houtte M; Butel C; Delaporte E; Peeters M
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
    Sukasem C; Churdboonchart V; Sukeepaisarncharoen W; Piroj W; Inwisai T; Tiensuwan M; Chantratita W
    Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.
    Brennan CA; Stramer SL; Holzmayer V; Yamaguchi J; Foster GA; Notari Iv EP; Schochetman G; Devare SG
    Transfusion; 2009 Jan; 49(1):125-33. PubMed ID: 18954404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
    Charpentier C; Larrouy L; Visseaux B; Landman R; Levittas M; Storto A; Damond F; Yazdanpanah Y; Yeni P; Brun-Vézinet F; Descamps D
    J Antimicrob Chemother; 2012 Jun; 67(6):1459-61. PubMed ID: 22382470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options.
    Chamberland A; Diabaté S; Sylla M; Anagounou S; Geraldo N; Zannou DM; Labbé AC; Worobey M; Alary M; Tremblay C
    Sex Transm Infect; 2012 Apr; 88(3):179-83. PubMed ID: 22158948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in Cambodia.
    Nouhin J; Ngin S; Martin PR; Marcy O; Kruy L; Ariey F; Peeters M; Chaix ML; Ayouba A; Nerrienet E
    AIDS Res Hum Retroviruses; 2009 May; 25(5):543-5. PubMed ID: 19388823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of drug resistance mutations among drug-naive patients in Morocco.
    Annaz HE; Recordon-Pinson P; Baba N; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):917-20. PubMed ID: 21087198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.
    Malet I; Fourati S; Charpentier C; Morand-Joubert L; Armenia D; Wirden M; Sayon S; Van Houtte M; Ceccherini-Silberstein F; Brun-Vézinet F; Perno CF; Descamps D; Capt A; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2011 Dec; 66(12):2827-30. PubMed ID: 21933786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil.
    Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA
    J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir.
    Svedhem V; Lindkvist A; Bergroth T; Knut L; Sönnerborg A
    J Med Virol; 2005 Aug; 76(4):447-51. PubMed ID: 15977242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
    Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.